» Articles » PMID: 26131310

Contemporary Perspective on Endogenous Myocardial Regeneration

Overview
Date 2015 Jul 2
PMID 26131310
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Considering the complex nature of the adult heart, it is no wonder that innate regenerative processes, while maintaining adequate cardiac function, fall short in myocardial jeopardy. In spite of these enchaining limitations, cardiac rejuvenation occurs as well as restricted regeneration. In this review, the background as well as potential mechanisms of endogenous myocardial regeneration are summarized. We present and analyze the available evidence in three subsequent steps. First, we examine the experimental research data that provide insights into the mechanisms and origins of the replicating cardiac myocytes, including cell populations referred to as cardiac progenitor cells (i.e., c-kit+ cells). Second, we describe the role of clinical settings such as acute or chronic myocardial ischemia, as initiators of pathways of endogenous myocardial regeneration. Third, the hitherto conducted clinical studies that examined different approaches of initiating endogenous myocardial regeneration in failing human hearts are analyzed. In conclusion, we present the evidence in support of the notion that regaining cardiac function beyond cellular replacement of dysfunctional myocardium via initiation of innate regenerative pathways could create a new perspective and a paradigm change in heart failure therapeutics. Reinitiating cardiac morphogenesis by reintroducing developmental pathways in the adult failing heart might provide a feasible way of tissue regeneration. Based on our hypothesis "embryonic recall", we present first supporting evidence on regenerative impulses in the myocardium, as induced by developmental processes.

Citing Articles

Progressive Reinvention or Destination Lost? Half a Century of Cardiovascular Tissue Engineering.

Zilla P, Deutsch M, Bezuidenhout D, Davies N, Pennel T Front Cardiovasc Med. 2020; 7:159.

PMID: 33033720 PMC: 7509093. DOI: 10.3389/fcvm.2020.00159.


Circular RNA (circRNA) CDYL Induces Myocardial Regeneration by ceRNA After Myocardial Infarction.

Zhang M, Wang Z, Cheng Q, Wang Z, Lv X, Wang Z Med Sci Monit. 2020; 26:e923188.

PMID: 32522972 PMC: 7304314. DOI: 10.12659/MSM.923188.


Biomimetic Model of Contractile Cardiac Tissue with Endothelial Networks Stabilized by Adipose-Derived Stromal/Stem Cells.

Morrissette-McAlmon J, Ginn B, Somers S, Fukunishi T, Thanitcul C, Rindone A Sci Rep. 2020; 10(1):8387.

PMID: 32433563 PMC: 7239907. DOI: 10.1038/s41598-020-65064-3.


Current Progress in the Rejuvenation of Aging Stem/Progenitor Cells for Improving the Therapeutic Effectiveness of Myocardial Repair.

Kaur G, Cai C Stem Cells Int. 2018; 2018:9308301.

PMID: 29760740 PMC: 5926481. DOI: 10.1155/2018/9308301.


Ablation of periostin inhibits post-infarction myocardial regeneration in neonatal mice mediated by the phosphatidylinositol 3 kinase/glycogen synthase kinase 3β/cyclin D1 signalling pathway.

Chen Z, Xie J, Hao H, Lin H, Wang L, Zhang Y Cardiovasc Res. 2017; 113(6):620-632.

PMID: 28453729 PMC: 5412017. DOI: 10.1093/cvr/cvx001.


References
1.
Anversa P, Kajstura J, Cheng W, Reiss K, Cigola E, Olivetti G . Insulin-like growth factor-1 and myocyte growth: the danger of a dogma part II. Induced myocardial growth: pathologic hypertrophy. Cardiovasc Res. 1996; 32(3):484-95. View

2.
Anversa P, Palackal T, SONNENBLICK E, Olivetti G, Meggs L, Capasso J . Myocyte cell loss and myocyte cellular hyperplasia in the hypertrophied aging rat heart. Circ Res. 1990; 67(4):871-85. DOI: 10.1161/01.res.67.4.871. View

3.
Ellison G, Torella D, Dellegrottaglie S, Perez-Martinez C, de Prado A, Vicinanza C . Endogenous cardiac stem cell activation by insulin-like growth factor-1/hepatocyte growth factor intracoronary injection fosters survival and regeneration of the infarcted pig heart. J Am Coll Cardiol. 2011; 58(9):977-86. DOI: 10.1016/j.jacc.2011.05.013. View

4.
Davis D, Zhang Y, Smith R, Cheng K, Terrovitis J, Malliaras K . Validation of the cardiosphere method to culture cardiac progenitor cells from myocardial tissue. PLoS One. 2009; 4(9):e7195. PMC: 2745677. DOI: 10.1371/journal.pone.0007195. View

5.
Gersh B, Simari R, Behfar A, Terzic C, Terzic A . Cardiac cell repair therapy: a clinical perspective. Mayo Clin Proc. 2009; 84(10):876-92. PMC: 2755807. DOI: 10.4065/84.10.876. View